Tranilastum
Tranilastum Uses, Dosage, Side Effects, Food Interaction and all others data.
Tranilastum is an antiallergic drug developed by Kissei Pharmaceuticals. In 1982, it was approved in Japan and South Korea for the management of bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
Trade Name | Tranilastum |
Generic | Tranilast |
Tranilast Other Names | Tranilast, Tranilastum |
Type | |
Formula | C18H17NO5 |
Weight | Average: 327.3313 Monoisotopic: 327.110672659 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
For the treatment of bronchial asthma, keloid and hypertrophic scar, and allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
Innovators Monograph
You find simplified version here Tranilastum